img

Global Tuberculosis Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Tuberculosis Treatment Market Research Report 2024

According to MRAResearch’s new survey, global Tuberculosis Treatment market is projected to reach US$ 1270.1 million in 2033, increasing from US$ 1018.3 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tuberculosis Treatment market research.
Key companies engaged in the Tuberculosis Treatment industry include Sanofi, Bayer, Eli Lilly, Labatec Pharma, Macleods Pharmaceuticals, Mylan, Novatis, Otsuka and Patheon, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Tuberculosis Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tuberculosis Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Tuberculosis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sanofi
Bayer
Eli Lilly
Labatec Pharma
Macleods Pharmaceuticals
Mylan
Novatis
Otsuka
Patheon
Pfizer
Segment by Type
Active TB
Latent TB

Segment by Application


Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Tuberculosis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Active TB
1.2.3 Latent TB
1.3 Market by Application
1.3.1 Global Tuberculosis Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Treatment Market Perspective (2018-2033)
2.2 Tuberculosis Treatment Growth Trends by Region
2.2.1 Global Tuberculosis Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Tuberculosis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Tuberculosis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Tuberculosis Treatment Market Dynamics
2.3.1 Tuberculosis Treatment Industry Trends
2.3.2 Tuberculosis Treatment Market Drivers
2.3.3 Tuberculosis Treatment Market Challenges
2.3.4 Tuberculosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Treatment Players by Revenue
3.1.1 Global Top Tuberculosis Treatment Players by Revenue (2018-2023)
3.1.2 Global Tuberculosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Tuberculosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Treatment Revenue
3.4 Global Tuberculosis Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Treatment Revenue in 2022
3.5 Tuberculosis Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Treatment Breakdown Data by Type
4.1 Global Tuberculosis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Tuberculosis Treatment Forecasted Market Size by Type (2024-2033)
5 Tuberculosis Treatment Breakdown Data by Application
5.1 Global Tuberculosis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Tuberculosis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Tuberculosis Treatment Market Size (2018-2033)
6.2 North America Tuberculosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Tuberculosis Treatment Market Size by Country (2018-2023)
6.4 North America Tuberculosis Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis Treatment Market Size (2018-2033)
7.2 Europe Tuberculosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Tuberculosis Treatment Market Size by Country (2018-2023)
7.4 Europe Tuberculosis Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Treatment Market Size (2018-2033)
8.2 Asia-Pacific Tuberculosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Tuberculosis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Tuberculosis Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tuberculosis Treatment Market Size (2018-2033)
9.2 Latin America Tuberculosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Tuberculosis Treatment Market Size by Country (2018-2023)
9.4 Latin America Tuberculosis Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Treatment Market Size (2018-2033)
10.2 Middle East & Africa Tuberculosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Tuberculosis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Tuberculosis Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Tuberculosis Treatment Introduction
11.1.4 Sanofi Revenue in Tuberculosis Treatment Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Tuberculosis Treatment Introduction
11.2.4 Bayer Revenue in Tuberculosis Treatment Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Tuberculosis Treatment Introduction
11.3.4 Eli Lilly Revenue in Tuberculosis Treatment Business (2018-2023)
11.3.5 Eli Lilly Recent Development
11.4 Labatec Pharma
11.4.1 Labatec Pharma Company Detail
11.4.2 Labatec Pharma Business Overview
11.4.3 Labatec Pharma Tuberculosis Treatment Introduction
11.4.4 Labatec Pharma Revenue in Tuberculosis Treatment Business (2018-2023)
11.4.5 Labatec Pharma Recent Development
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Detail
11.5.2 Macleods Pharmaceuticals Business Overview
11.5.3 Macleods Pharmaceuticals Tuberculosis Treatment Introduction
11.5.4 Macleods Pharmaceuticals Revenue in Tuberculosis Treatment Business (2018-2023)
11.5.5 Macleods Pharmaceuticals Recent Development
11.6 Mylan
11.6.1 Mylan Company Detail
11.6.2 Mylan Business Overview
11.6.3 Mylan Tuberculosis Treatment Introduction
11.6.4 Mylan Revenue in Tuberculosis Treatment Business (2018-2023)
11.6.5 Mylan Recent Development
11.7 Novatis
11.7.1 Novatis Company Detail
11.7.2 Novatis Business Overview
11.7.3 Novatis Tuberculosis Treatment Introduction
11.7.4 Novatis Revenue in Tuberculosis Treatment Business (2018-2023)
11.7.5 Novatis Recent Development
11.8 Otsuka
11.8.1 Otsuka Company Detail
11.8.2 Otsuka Business Overview
11.8.3 Otsuka Tuberculosis Treatment Introduction
11.8.4 Otsuka Revenue in Tuberculosis Treatment Business (2018-2023)
11.8.5 Otsuka Recent Development
11.9 Patheon
11.9.1 Patheon Company Detail
11.9.2 Patheon Business Overview
11.9.3 Patheon Tuberculosis Treatment Introduction
11.9.4 Patheon Revenue in Tuberculosis Treatment Business (2018-2023)
11.9.5 Patheon Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Tuberculosis Treatment Introduction
11.10.4 Pfizer Revenue in Tuberculosis Treatment Business (2018-2023)
11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tuberculosis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Active TB
Table 3. Key Players of Latent TB
Table 4. Global Tuberculosis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Tuberculosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Tuberculosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Tuberculosis Treatment Market Share by Region (2018-2023)
Table 8. Global Tuberculosis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Tuberculosis Treatment Market Share by Region (2024-2033)
Table 10. Tuberculosis Treatment Market Trends
Table 11. Tuberculosis Treatment Market Drivers
Table 12. Tuberculosis Treatment Market Challenges
Table 13. Tuberculosis Treatment Market Restraints
Table 14. Global Tuberculosis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Tuberculosis Treatment Market Share by Players (2018-2023)
Table 16. Global Top Tuberculosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Treatment as of 2022)
Table 17. Ranking of Global Top Tuberculosis Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Tuberculosis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tuberculosis Treatment Product Solution and Service
Table 21. Date of Enter into Tuberculosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tuberculosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Tuberculosis Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Tuberculosis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Tuberculosis Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Tuberculosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Tuberculosis Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Tuberculosis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Tuberculosis Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Tuberculosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Tuberculosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Tuberculosis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Tuberculosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Tuberculosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Tuberculosis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Tuberculosis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Tuberculosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Tuberculosis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Tuberculosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Tuberculosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Tuberculosis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Tuberculosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Tuberculosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Tuberculosis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Tuberculosis Treatment Product
Table 49. Sanofi Revenue in Tuberculosis Treatment Business (2018-2023) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Bayer Company Detail
Table 52. Bayer Business Overview
Table 53. Bayer Tuberculosis Treatment Product
Table 54. Bayer Revenue in Tuberculosis Treatment Business (2018-2023) & (US$ Million)
Table 55. Bayer Recent Development
Table 56. Eli Lilly Company Detail
Table 57. Eli Lilly Business Overview
Table 58. Eli Lilly Tuberculosis Treatment Product
Table 59. Eli Lilly Revenue in Tuberculosis Treatment Business (2018-2023) & (US$ Million)
Table 60. Eli Lilly Recent Development
Table 61. Labatec Pharma Company Detail
Table 62. Labatec Pharma Business Overview
Table 63. Labatec Pharma Tuberculosis Treatment Product
Table 64. Labatec Pharma Revenue in Tuberculosis Treatment Business (2018-2023) & (US$ Million)
Table 65. Labatec Pharma Recent Development
Table 66. Macleods Pharmaceuticals Company Detail
Table 67. Macleods Pharmaceuticals Business Overview
Table 68. Macleods Pharmaceuticals Tuberculosis Treatment Product
Table 69. Macleods Pharmaceuticals Revenue in Tuberculosis Treatment Business (2018-2023) & (US$ Million)
Table 70. Macleods Pharmaceuticals Recent Development
Table 71. Mylan Company Detail
Table 72. Mylan Business Overview
Table 73. Mylan Tuberculosis Treatment Product
Table 74. Mylan Revenue in Tuberculosis Treatment Business (2018-2023) & (US$ Million)
Table 75. Mylan Recent Development
Table 76. Novatis Company Detail
Table 77. Novatis Business Overview
Table 78. Novatis Tuberculosis Treatment Product
Table 79. Novatis Revenue in Tuberculosis Treatment Business (2018-2023) & (US$ Million)
Table 80. Novatis Recent Development
Table 81. Otsuka Company Detail
Table 82. Otsuka Business Overview
Table 83. Otsuka Tuberculosis Treatment Product
Table 84. Otsuka Revenue in Tuberculosis Treatment Business (2018-2023) & (US$ Million)
Table 85. Otsuka Recent Development
Table 86. Patheon Company Detail
Table 87. Patheon Business Overview
Table 88. Patheon Tuberculosis Treatment Product
Table 89. Patheon Revenue in Tuberculosis Treatment Business (2018-2023) & (US$ Million)
Table 90. Patheon Recent Development
Table 91. Pfizer Company Detail
Table 92. Pfizer Business Overview
Table 93. Pfizer Tuberculosis Treatment Product
Table 94. Pfizer Revenue in Tuberculosis Treatment Business (2018-2023) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Tuberculosis Treatment Market Share by Type: 2022 VS 2033
Figure 3. Active TB Features
Figure 4. Latent TB Features
Figure 5. Global Tuberculosis Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Tuberculosis Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Tuberculosis Treatment Report Years Considered
Figure 10. Global Tuberculosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Tuberculosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Tuberculosis Treatment Market Share by Region: 2022 VS 2033
Figure 13. Global Tuberculosis Treatment Market Share by Players in 2022
Figure 14. Global Top Tuberculosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Tuberculosis Treatment Revenue in 2022
Figure 16. North America Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Tuberculosis Treatment Market Share by Country (2018-2033)
Figure 18. United States Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Tuberculosis Treatment Market Share by Country (2018-2033)
Figure 22. Germany Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Tuberculosis Treatment Market Share by Region (2018-2033)
Figure 30. China Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Tuberculosis Treatment Market Share by Country (2018-2033)
Figure 38. Mexico Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Tuberculosis Treatment Market Share by Country (2018-2033)
Figure 42. Turkey Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Tuberculosis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Sanofi Revenue Growth Rate in Tuberculosis Treatment Business (2018-2023)
Figure 45. Bayer Revenue Growth Rate in Tuberculosis Treatment Business (2018-2023)
Figure 46. Eli Lilly Revenue Growth Rate in Tuberculosis Treatment Business (2018-2023)
Figure 47. Labatec Pharma Revenue Growth Rate in Tuberculosis Treatment Business (2018-2023)
Figure 48. Macleods Pharmaceuticals Revenue Growth Rate in Tuberculosis Treatment Business (2018-2023)
Figure 49. Mylan Revenue Growth Rate in Tuberculosis Treatment Business (2018-2023)
Figure 50. Novatis Revenue Growth Rate in Tuberculosis Treatment Business (2018-2023)
Figure 51. Otsuka Revenue Growth Rate in Tuberculosis Treatment Business (2018-2023)
Figure 52. Patheon Revenue Growth Rate in Tuberculosis Treatment Business (2018-2023)
Figure 53. Pfizer Revenue Growth Rate in Tuberculosis Treatment Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed